Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Anifrolumab helped a woman with severe lupus achieve remission when other treatments failed.

CXCR3+ T cells and B cells drive skin disease and hair loss in lupus, with potential targets identified for treatment.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Type I interferons may help treat skin issues in lupus and dermatomyositis.

Vitiligo and alopecia areata may have similar causes despite their differences.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Type I interferons play a key role in the development of various skin diseases.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Smart biomaterials and dressings show promise in treating chronic skin diseases by improving drug delivery and minimizing side effects.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Multiple pregnancies prevent skin disease but worsen kidney disease in certain mice.

NK cells play a role in skin diseases like eczema and psoriasis.

Researchers found four distinct fibroblast types in human skin, which could help in treating wounds and fibrotic diseases.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.